MIMETAS develops organ-on-a-chip products and tissue models for compound testing, screening and fundamental research applications... Read more
Mimetas Co-CEO: Jos Joore

Co-CEO

Jos Joore

CEO Approval Rating

87/100

Est. Annual Revenue
$5.0-25M
Agree?
Est. Employees
100-250
Agree?
Funding
$31.4M

Mimetas Competitors

1Caladrius
2Ncardia
3Cesca
4OcellO
5InSphero
6Nagi Bioscience
7Mesoblast
8Asterias Biotherapeutics, Inc.
9Mekonos
10Sangamo

Trending Companies